- Schmidt RL, Witt BL, Matynia AP, Barraza G, Layfield LJ, Adler DG. Rapid on-site evaluation increases endoscopic ultrasound-guided fine-needle aspiration adequacy for pancreatic lesions. Dig Dis Sci. 2013;58(3):872–882.
- Hasan MK, Hawes RH. EUS-guided FNA of solid pancreas tumors. Gastrointest Endosc Clin N Am. 2012;22(2):155–167.
- Bluen BE, Lachter J, Khamaysi I, et al. Accuracy and quality assessment of EUS-FNA: a single-center large cohort of biopsies. Diagn Ther Endosc. 2012;(2012):article ID 139563. doi:101155/2012/139563.
- Puli SR, Bechtold ML, Buxbaum JL, Eloubeidi MA. How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass?: A meta-analysis and systematic review. Pancreas. 2013;42(1):20–26.
- Webb K, Hwang JH. Endoscopic ultrasound-fine needle aspiration versus core biopsy for the diagnosis of subepithelial tumors. Clin Endos. 2013;46(5):441–444.
- Levy MJ, Jondal ML, Clain J, Wiersema MJ. Preliminary experience with a EUS-guided trucut biopsy needle compared with EUS-guided FNA. Gastrointest Endosc. 2003;57(1):101–106.
- Dwyer J, Pantanowitz L, Ohori NP, et al. Endoscopic ultrasound-guided FNA and ProCore biopsy in sampling pancreatic and intra-abdominal masses. Cancer Cytopathol. 2016;124(2):110–121.
- Witt BL, Adler DG, Hilden K, Layfield LJ. A comparative needle study: EUS-FNA procedures using the HD ProCore and EchoTip 22-gauge needle types. Diagn Cytopathol. 2013;41(12):1069–1074.
- Bang JY, Hawes R, Varadarajulu S. A meta-analysis comparing ProCore and standard fine-needle aspiration needles for endoscopic ultrasound-guided tissue acquisition. Endoscopy. 2016;48(4):339–349.
- Sherman WH, Chu K, Chabot J, et al. Neoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable pancreatic adenocarcinoma. Cancer. 2015;121(5):673–680.
Dr. Pendse is a surgical pathology fellow and Dr. Dodd is a professor of pathology and director of cytopathology, Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill. Dr. Dodd is a member of the CAP Cytopathology Committee.
Pages: 1 2